Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
09/27/2012 | US20120244556 Markers for identifying tumor cells, methods and kit thereof |
09/27/2012 | US20120244546 Antibodies specific to carbamazepine |
09/27/2012 | US20120244272 Non-astringent protein products |
09/27/2012 | US20120244232 Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
09/27/2012 | US20120244189 Treatment of infections |
09/27/2012 | US20120244184 Modified peptide vaccine derived from influenza m2 |
09/27/2012 | US20120244178 Plasmodium falciparum antigens |
09/27/2012 | US20120244176 Protein having immunogenicity of cedar pollen, polynucleotide encoding the protein, and use thereof |
09/27/2012 | US20120244175 Tumor specific animal proteins |
09/27/2012 | US20120244174 Treatment of tauopathies |
09/27/2012 | US20120244172 Conjudates of Pyrrolo[1,4]Benzodiazepine Dimers As Anticancer Agents |
09/27/2012 | US20120244159 Specific Antibodies To Amyloid Beta Peptide, Pharmaceutical Compositions And Methods Of Use Thereof |
09/27/2012 | US20120244150 Anti-veev humanized antibody |
09/27/2012 | US20120244144 Pertussis antibodies and uses thereof |
09/27/2012 | US20120244143 Drawn silk egel fibers and methods of making same |
09/27/2012 | US20120244136 Cardiac-Specific Protein Targeting Domain |
09/27/2012 | US20120244132 T-cell receptor |
09/27/2012 | US20120244123 Therapeutic agents |
09/27/2012 | US20120244112 Mutant interleukin-2 polypeptides |
09/27/2012 | US20120244067 Methods for inducing reversible stasis |
09/27/2012 | DE112010002842T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation |
09/27/2012 | DE112010000887T5 Pflanzen mit gesteigerten Ertragsmerkmalen und Verfahren zu deren Herstellung Plants having enhanced yield-related traits and processes for their preparation |
09/27/2012 | CA2831000A1 Method of recovering plant-derived proteins |
09/27/2012 | CA2830953A1 Method and compositions for cellular immunotherapy |
09/27/2012 | CA2830943A1 Peptides capable of forming a covalent complex, and uses thereof |
09/27/2012 | CA2830901A1 Immunogenic compositions in particulate form and methods for producing the same |
09/27/2012 | CA2830805A1 Constructs and method for regulating gene expression or for detecting and controlling a dna locus in eukaryotes |
09/27/2012 | CA2830787A1 Dominant negative hsp110 mutant and its use in prognosing and treating cancers |
09/27/2012 | CA2830772A1 Polypeptides with affinity for heat shock proteins (hsps) and hsp associated complexes (hacs) and their use in diagnosis and therapy |
09/27/2012 | CA2830628A1 Composition for treatment and diagnosis of pancreatic cancer |
09/27/2012 | CA2830600A1 Compositions and methods for enhancing the pluripotency of stem cells |
09/27/2012 | CA2830259A1 Peptides for suppressing inflammation |
09/27/2012 | CA2830012A1 New conjugated molecules comprising a peptide derived from the cd4 receptor coupled to a polyanionic polypeptide for the treatment of aids |
09/27/2012 | CA2828477A1 Compositions and methods for separating, characterizing and administering soluble selenoglycoproteins |
09/27/2012 | CA2826490A1 R2r1/2 in diagnosis and therapy |
09/27/2012 | CA2820956A1 Methods and compositions comprising il-7 receptor ligands |
09/26/2012 | EP2503338A2 CD73 as a biomarker for monitoring development of diseases and assessing the efficacy of therapies |
09/26/2012 | EP2502998A2 Recombinant toxin A/ToxinB vaccine against clostridium difficile |
09/26/2012 | EP2502995A1 Pharmaceutical composition |
09/26/2012 | EP2502991A1 Transformant which produces collagen wherein both lysine residue and proline residue are hydroxylated |
09/26/2012 | EP2502939A1 Nonnatural collagen-like protein and use thereof |
09/26/2012 | EP2502934A1 Single chain antigen recognizing constructs (scARCs) stabilized by the introduction of novel disulfide bonds |
09/26/2012 | EP2502933A2 Method for preparing gintonin, which is a novel glycolipoprotein from panax ginseng, and gintonin, which is a novel glycolipoprotein, prepared by the method |
09/26/2012 | EP2502932A1 Novel beta-oxidation pathway and hemicascomycetes yeast mutants |
09/26/2012 | EP2502930A2 Method and compositions for detecting botulinum neurotoxin |
09/26/2012 | EP2502906A2 Trypsin-like serine protease inhibitors, their preparation and use |
09/26/2012 | EP2502634A1 Herpes simplex virus combined subunit vaccines and methods of use thereof |
09/26/2012 | EP2502633A1 Recombinant plasmid DNA pMSIN4, encoding a hybrid polypeptide comprising human insulin precursor, E. coli strain BL21 (DE3) / pMSIN4 - producer of recombinant human insulin, the method for the recombinant human insulin production |
09/26/2012 | EP2502628A2 Polynucleotides and polypeptide sequences involved in cancer |
09/26/2012 | EP2502496A1 Flowering inducer |
09/26/2012 | EP2502494A2 Novel alpha-galactosidases |
09/26/2012 | EP2502493A2 Novel alpha-galactosidases |
09/26/2012 | EP2502492A2 Novel alpha-galactosidases |
09/26/2012 | EP2502491A2 Novel alpha-galactosidases |
09/26/2012 | EP2501816A1 Plants with increased yield |
09/26/2012 | EP2501815A1 Variegation in plants |
09/26/2012 | EP2501814A1 Inhibitors of centrosomal clustering |
09/26/2012 | EP2501796A1 Recombinant microorganisms |
09/26/2012 | EP2501792A2 Gh61 polypeptides having detergency enhancing effect |
09/26/2012 | EP2501724A2 Monoclonal antibodies and diagnostic uses thereof |
09/26/2012 | EP2501720A2 Ifn inhibitors in the treatment of motoneuron diseases |
09/26/2012 | EP2501719A2 Peptides and methods for the detection of lyme disease antibodies |
09/26/2012 | EP2501718A2 Peptides, devices, and methods for the detection of ehrlichia antibodies |
09/26/2012 | EP2501717A1 Enhanced malaria msp-1 subunit vaccine |
09/26/2012 | EP2501716A2 Compositions for increasing polypeptide stability and activity, and related methods |
09/26/2012 | EP2501713A1 Method for treating blood plasma including a step of washing by means of dispersion |
09/26/2012 | EP2501712A1 Process for the synthesis of ac-arg-cyclo(cys-d-ala-his-d-phe-arg-trp-cys)-nh2 |
09/26/2012 | EP2501711A1 Compounds and methods for purifying peptides produced by solid phase peptide synthesis |
09/26/2012 | EP2501414A2 Smndelta7 degron: novel compositions and methods of use |
09/26/2012 | EP2501407A1 Anti-orai1 antigen binding proteins and uses thereof |
09/26/2012 | EP2501402A1 Suppression of cancer metastasis |
09/26/2012 | EP2501401A1 Method for purifying factor b |
09/26/2012 | CN202450012U Albumen powder production system |
09/26/2012 | CN1799625B Preparation of officinal interleukin |
09/26/2012 | CN1788088B Mutant vesicular stomatitis viruses and use thereof |
09/26/2012 | CN1681930B Polypeptide having signal sequence containing FIVSI motif and oligonucleotide encoding said motif |
09/26/2012 | CN1674933B 疫苗组合物 Vaccine compositions |
09/26/2012 | CN1662663B DNA enzyme to inhibit plasminogen activator inhibitor-1 |
09/26/2012 | CN102695796A Cells, nucleic acids, enzymes, and use thereof, and methods for the production of sophorolipids |
09/26/2012 | CN102695723A Improved neurturin molecules |
09/26/2012 | CN102695722A Antibodies and epitopes specific to misfolded prion protein |
09/26/2012 | CN102695721A Stabilization of bio-sensors for in vivo applications |
09/26/2012 | CN102695720A Polypeptides derived from thermoascus crustaceus having cellulolytic enhancing activity and polynucleotides encoding same |
09/26/2012 | CN102695719A Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
09/26/2012 | CN102695718A Method for extracting staphylococcus aureus antigen, reagent for extracting staphylococcus aureus antigen, and method for testing staphylococcus aureus |
09/26/2012 | CN102695717A T-cell receptor |
09/26/2012 | CN102695716A Sugar chain marker as measure of disease conditions of hepatic diseases |
09/26/2012 | CN102695527A Molecular probe for imaging of pancreatic islet, and use thereof |
09/26/2012 | CN102695524A Virus like particles comprising target proteins fused to plant viral coat proteins |
09/26/2012 | CN102695523A Combination vaccines against respiratory tract diseases |
09/26/2012 | CN102692509A Method for diagnosing bovine tuberculosis mediated by recombinant protein mixture and regent thereof |
09/26/2012 | CN102690831A El-b3a gene in soybean growth period and coding protein thereof |
09/26/2012 | CN102690830A Salt tolerant gene and its application |
09/26/2012 | CN102690771A Functional lactobacillus plantarum and application thereof |
09/26/2012 | CN102690370A Comprehensive utilization technique of marine fish bones |
09/26/2012 | CN102690350A Anti-il-22ra antibodies and binding partners and methods of using in inflammation |
09/26/2012 | CN102690348A Method for preparing reagent-grade phycocyanin on large scale |
09/26/2012 | CN102690347A Method for separating I-type precollagen amino terminal peptide |
09/26/2012 | CN102690346A Polypeptide treating diabetes, its preparation method and application |
09/26/2012 | CN102690345A Human annexin V variant and its expression, preparation method and use |